{"id":"W2588586288","doi":"10.1093/annonc/mdw370.100","title":"Aflibercept plus FOLFIRI for 2nd line treatment of metastatic colorectal cancer (mCRC): Long-term safety observation from the global aflibercept safety and quality-of-life (QoL) program (ASQoP)","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; FOLFIRI; Aflibercept; Oxaliplatin; Bevacizumab; Internal medicine; Population; Adverse effect; Oncology; Surgery; Colorectal cancer; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001424337,0.0003875715,0.001163329,0.0003201716,0.0002818902,0.0006231326,0.0002910352,0.0004623752,0.001628678],"category_scores_gemma":[0.001589136,0.0001448556,0.00113501,0.0003535486,0.0002601391,0.0007712069,0.0002246529,0.001627602,0.000352483],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005767173,"about_ca_system_score_gemma":0.000509448,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006381201,"about_ca_topic_score_gemma":0.001599571,"domain_scores_codex":[0.9995664,0.0001799698,0.00003783967,0.00006426219,0.00006883184,0.00008256175],"domain_scores_gemma":[0.9990993,0.0002254831,0.0003129233,0.00009271615,0.0000605708,0.0002090068],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4703771,0.01260488,0.04073283,0.0008319039,0.003458266,0.0003070147,0.0001998049,0.002036894,0.01198146,0.0001824906,0.003299554,0.4539877],"study_design_scores_gemma":[0.1422013,0.5774421,0.2540351,0.0001809969,0.003949059,0.001459138,0.00022366,0.003184558,0.008535529,0.0005487697,0.00815114,0.00008873269],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912735,0.005856073,0.0003285802,0.0003046638,0.0000721949,0.0001587827,0.0006411825,0.00004747299,0.00131757],"genre_scores_gemma":[0.996378,0.001257946,0.0003521293,0.0003035695,0.00008353695,0.0000730629,0.0008753654,0.000007386913,0.0006690522],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001628678,"threshold_uncertainty_score":0.007532716,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2003086427191504,"score_gpt":0.4573791860957115,"score_spread":0.2570705433765612,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}